Literature DB >> 19563476

Therapeutic itineraries of patients with ulcerated forms of Mycobacterium ulcerans (Buruli ulcer) disease in a rural health zone in the Democratic Republic of Congo.

Kapay Kibadi1, Marleen Boelaert, Makanzu Kayinua, Jean-Bedel Minuku, Jean-Jacques Muyembe-Tamfum, Françoise Portaels, Pierre Lefèvre.   

Abstract

OBJECTIVE: To describe lay perceptions of the ulcerated forms of Mycobacterium ulcerans, commonly called Buruli ulcer (BU), and therapeutic itineraries of BU patients in a rural area of the Democratic Republic of Congo.
METHODS: Qualitative research consisting of semi-structured interviews of 19 patients with clinical signs of BU and 12 in-depth interviews of confirmed cases allowing for a detailed reconstruction of the itineraries followed.
RESULTS: The first symptoms of BU are perceived as mild. The perceived seriousness of the disease increases as the ulceration persists, increases in size or results in complications. Knowledge about the biomedical aetiology of the disease is scarce; it is commonly believed to be due to witches' attacks or bad fate. Four therapeutic paths are taken: self-medication, traditional therapy, the church and the health centre. However lay perception, recourse to traditional treatments and self-medication only partially explain the long delays in diagnosis (on average 6 months); the main problem lies with health providers, particularly the lack of proper diagnostic capability.
CONCLUSIONS: Diagnostic capabilities at health centre level need to be strengthened through training and supervision. Engaging with the population and the traditional healers would render health promotion messages on BU more relevant and culturally acceptable.

Entities:  

Mesh:

Year:  2009        PMID: 19563476     DOI: 10.1111/j.1365-3156.2009.02324.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  17 in total

1.  Mycobacterium ulcerans infection (Buruli ulcer) on the face: a comparative analysis of 13 clinically suspected cases from the Democratic Republic of Congo.

Authors:  Delphin M Phanzu; Roger L Mahema; Patrick Suykerbuyk; Désiré-Hubert B Imposo; Linda F Lehman; Elie Nduwamahoro; Wayne M Meyers; Marleen Boelaert; Françoise Portaels
Journal:  Am J Trop Med Hyg       Date:  2011-12       Impact factor: 2.345

2.  "I did not see a need to get tested before, everything was going well with my health": a qualitative study of HIV-testing decision-making in KwaZulu-Natal, South Africa.

Authors:  Shema Tariq; Susie Hoffman; Gita Ramjee; Joanne E Mantell; Jessica L Phillip; Kelly Blanchard; Naomi Lince-Deroche; Theresa M Exner
Journal:  AIDS Care       Date:  2017-07-11

Review 3.  Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans.

Authors:  Dezemon Zingue; Amar Bouam; Roger B D Tian; Michel Drancourt
Journal:  Clin Microbiol Rev       Date:  2017-12-13       Impact factor: 26.132

4.  A painful journey to antivenom: The therapeutic itinerary of snakebite patients in the Brazilian Amazon (The QUALISnake Study).

Authors:  Joseir Saturnino Cristino; Guilherme Maciel Salazar; Vinícius Azevedo Machado; Eduardo Honorato; Altair Seabra Farias; João Ricardo Nickenig Vissoci; Alexandre Vilhena Silva Neto; Marcus Lacerda; Fan Hui Wen; Wuelton Marcelo Monteiro; Jacqueline Almeida Gonçalves Sachett
Journal:  PLoS Negl Trop Dis       Date:  2021-03-04

5.  Effect of a control project on clinical profiles and outcomes in buruli ulcer: a before/after study in Bas-Congo, Democratic Republic of Congo.

Authors:  Delphin Mavinga Phanzu; Patrick Suykerbuyk; Désiré Bofunga B Imposo; Philippe Ngwala Lukanu; Jean-Bedel Masamba Minuku; Linda F Lehman; Paul Saunderson; Bouke C de Jong; Pascal Tshindele Lutumba; Françoise Portaels; Marleen Boelaert
Journal:  PLoS Negl Trop Dis       Date:  2011-12-27

6.  What role do traditional beliefs play in treatment seeking and delay for Buruli ulcer disease?--insights from a mixed methods study in Cameroon.

Authors:  Koen Peeters Grietens; Elizabeth Toomer; Alphonse Um Boock; Susanna Hausmann-Muela; Hans Peeters; Kirezi Kanobana; Charlotte Gryseels; Joan Muela Ribera
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

7.  Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followed by rifampin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans disease.

Authors:  Richard O Phillips; Fred S Sarfo; Mohammed K Abass; Justice Abotsi; Tuah Wilson; Mark Forson; Yaw A Amoako; William Thompson; Kingsley Asiedu; Mark Wansbrough-Jones
Journal:  Antimicrob Agents Chemother       Date:  2013-12-09       Impact factor: 5.191

Review 8.  Persistent digestive disorders in the tropics: causative infectious pathogens and reference diagnostic tests.

Authors:  Sören L Becker; Jürg Vogt; Stefanie Knopp; Marcus Panning; David C Warhurst; Katja Polman; Hanspeter Marti; Lutz von Müller; Cedric P Yansouni; Jan Jacobs; Emmanuel Bottieau; Moussa Sacko; Suman Rijal; Fransiska Meyanti; Michael A Miles; Marleen Boelaert; Pascal Lutumba; Lisette van Lieshout; Eliézer K N'Goran; François Chappuis; Jürg Utzinger
Journal:  BMC Infect Dis       Date:  2013-01-24       Impact factor: 3.090

9.  Perceptions on the effectiveness of treatment and the timeline of Buruli ulcer influence pre-hospital delay reported by healthy individuals.

Authors:  Marike Alferink; Tjip S van der Werf; Ghislain E Sopoh; Didier C Agossadou; Yves T Barogui; Frederic Assouto; Chantal Agossadou; Roy E Stewart; Ymkje Stienstra; Adelita V Ranchor
Journal:  PLoS Negl Trop Dis       Date:  2013-01-17

10.  Diagnosis of neglected tropical diseases among patients with persistent digestive disorders (diarrhoea and/or abdominal pain ≥14 days): Pierrea multi-country, prospective, non-experimental case-control study.

Authors:  Katja Polman; Sören L Becker; Emilie Alirol; Nisha K Bhatta; Narayan R Bhattarai; Emmanuel Bottieau; Martin W Bratschi; Sakib Burza; Jean T Coulibaly; Mama N Doumbia; Ninon S Horié; Jan Jacobs; Basudha Khanal; Aly Landouré; Yodi Mahendradhata; Filip Meheus; Pascal Mertens; Fransiska Meyanti; Elsa H Murhandarwati; Eliézer K N'Goran; Rosanna W Peeling; Raffaella Ravinetto; Suman Rijal; Moussa Sacko; Rénion Saye; Pierre H H Schneeberger; Céline Schurmans; Kigbafori D Silué; Jarir A Thobari; Mamadou S Traoré; Lisette van Lieshout; Harry van Loen; Kristien Verdonck; Lutz von Müller; Cédric P Yansouni; Joel A Yao; Patrick K Yao; Peiling Yap; Marleen Boelaert; François Chappuis; Jürg Utzinger
Journal:  BMC Infect Dis       Date:  2015-08-18       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.